Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.39B P/E - EPS this Y -9.90% Ern Qtrly Grth -
Income -96.75M Forward P/E -13.64 EPS next Y -51.00% 50D Avg Chg -25.00%
Sales - PEG -1.56 EPS past 5Y - 200D Avg Chg 10.00%
Dividend N/A Price/Book 3.60 EPS next 5Y 40.00% 52W High Chg -46.00%
Recommedations 1.50 Quick Ratio 37.55 Shares Outstanding 110.80M 52W Low Chg 449.00%
Insider Own 6.03% ROA -11.57% Shares Float 104.78M Beta 1.00
Inst Own 75.17% ROE -14.80% Shares Shorted/Prior 15.91M/17.70M Price 13.91
Gross Margin - Profit Margin - Avg. Volume 2,851,827 Target Price 113.55
Oper. Margin - Earnings Date Oct 23 Volume 1,253,300 Change -1.77%
About Viking Therapeutics, Inc.

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

Viking Therapeutics, Inc. News
11/22/24 RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?
11/22/24 Why Is Viking Therapeutics (VKTX) Down 29.5% Since Last Earnings Report?
11/22/24 VKTX Stock Loses Over $1B in a Month: How to Play the Stock?
11/21/24 Do Redditors Think That Viking Therapeutics Inc. (VKTX) Has a Big Upside Potential?
11/20/24 Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs
11/19/24 Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024
11/18/24 3 Things You Need to Know if You Buy Viking Therapeutics Today
11/17/24 Is It Too Late to Buy Viking Therapeutics Stock?
11/16/24 Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On.
11/15/24 Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?
11/13/24 Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?
11/13/24 Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly?
11/12/24 Viking Therapeutics to Present Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024
11/10/24 Is Viking Therapeutics a Buy on the Dip?
11/08/24 4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart Move
11/07/24 Got $5,000? Viking Therapeutics Stock Just Got a Big New Green Flag
11/05/24 Viking Therapeutics Offers An Obesity Drug for Healthy Adults
11/05/24 Viking stock fluctuates amid manufacturing concerns with obesity pill
11/05/24 Is Viking Therepautics a Buy Now?
11/04/24 Why Viking Therapeutics Stock Plummeted After Soaring Today
VKTX Chatroom

User Image Supercat1983 Posted - 5 minutes ago

$VKTX where dit you seen this??

User Image Supercat1983 Posted - 7 minutes ago

$VKTX

User Image samuelm7 Posted - 3 hours ago

$VKTX Can RFK Jr. Limit Ozempic Access as HHS Chief? Here’s What to Know - The New York Times https://www.nytimes.com/2024/11/22/health/rfk-jr-ozempic-drugs-fda.html

User Image Saguru Posted - 3 hours ago

$VKTX great article on Barrons this week on over blown concerns with RFK getting in there, must read

User Image arnolddiver Posted - 4 hours ago

$VKTX OUCH. Trump’s pick for FDA chief tonight is Dr. Marty Makary, a Johns Hopkins surgeon who specializes in oncology. The dude is a big advocate of RFK Jr and will work directly under him. RFK Jr has talked very negative about weight loss drugs and big pharma corruption. I would also not want to be a covid vax maker or big food corp. Oncology focusing on natural immunity will reap the benefits of this new FDA chief. CAR-T already attracting the most vc capital now. Let’s see how viking trades next week.

User Image dick_dasterdly Posted - 5 hours ago

$VKTX Just keep loading. Don't complicate this. You either believe , or ya do not. Your trucks can get in..right after mine.

User Image imbimmer Posted - 5 hours ago

$VKTX He needs to talk to Elon.

User Image lowfloatscambuster Posted - 6 hours ago

$VKTX not great optics

User Image biolover Posted - 6 hours ago

$VKTX this FDA pick seems good one. I just listened to the guy. I remember him during Covid. But just listened again and he has some wise ideas such as working against indiscriminate use of antibiotics and hormone replacement thereoah. and seem competent cancer surgeon at John’s Hopkins. He may reduce unnecessary delays at FDA.

User Image Bangi24 Posted - 6 hours ago

$VKTX https://x.com/adamfeuerstein/status/1860132748033499506?s=46

User Image Oknrv Posted - 8 hours ago

$VKTX Buy 🔫s. Stay fit 🍅🍆🥔🥕🫑🥒🫛🍄‍🟫!

User Image judgeyoung2 Posted - 9 hours ago

$VKTX manifesting a sunday buyout announcement yet again 😌

User Image CallThemOut Posted - 9 hours ago

$ALT Hahaha sounds good. EuPort 2035 Pemvi 2039 Nice try not looking murky like $VKTX You can change your handle, give throw different things and see if it sticks. Nothing does. Also try mixing GLP-1, gcg and EuPort to make generic after 2035 hahaha just in case you bring that up.

User Image HopefulCass Posted - 10 hours ago

$VKTX Brian : Sell. The. Fucking. Thing.

User Image jjhar Posted - 10 hours ago

$VKTX Near term catalysts: I would expect the VKTX-FDA meeting about Phase 3 trials to take place in the next 3-4 weeks before the xmas holiday. If they are partnering with anyone on the Phase 3 trial, I would expect an announcement around the same time or shortly afterwards so they can focus on preparations. Should get interesting here one way or another!

User Image fuegie Posted - 10 hours ago

$VKTX have a good weekend everybody, i feel like we finally break out of this ascending triangle next week back towards $60+.

User Image Gostrongx Posted - 10 hours ago

$VKTX $mrk $PFE Lets get this done tomorrow and announce on Monday! Cash/share deal $125

User Image uknic Posted - 11 hours ago

$VKTX @pharmdca twitter

User Image ItSaulGoodMaan Posted - 11 hours ago

$VKTX sell the fucking company

User Image JuggernautRaider Posted - 11 hours ago

@Marten_Bag few of us would be tough enough to work at Workhorse. $WKHS should buy what’s left of $VEV and incorporate it in Ohio. God Bless the US! ~JeffReeNah Jay “BoneSaw” Conroy I played football at Hudson and then for Northwestern. I am cheering for Indiana over OSU. Also: 1) sell $NVO (Novo Nordisk) 2) hold $LLY (Indiana’s Eli Lilly) 3) buy $VKTX (superior GLP-1 and NASH asset - in California Biotech!!!)

User Image DG20 Posted - 11 hours ago

$VKTX If you’re so confident you’re right then you shouldn’t have closed your position today…

User Image salmonbrain Posted - 11 hours ago

$VKTX that spike was partially me covering my short going into the weekend, dont worry I will be back Monday at the open (or premarket) adding it back on

User Image LFG1999 Posted - 11 hours ago

$VKTX waiting buyout news by $MRK or a manufacturing partnership announcement. Next near term catalysts

User Image MattSecurities Posted - 11 hours ago

@jaeeegeee Yeah I am way up, so I am not risking much. I think I am going to trim like 25% of my $rklb position which is still well over what I put into it, and move the capital into something I think has a better chance of doubling or more in the next year to 18 months (probably $VKTX on BO potential or $OTLK on drug approval), since I don't think this will go to $50 in 2025. If I am right on the other two and RKLB stays in in the $25 range for a while, I could see myself buying back in later. Then again, I could always be wrong and RKLB could get a huge contract or something.

User Image betachaser Posted - 12 hours ago

$VKTX the whole sector is hurting - need tutes to come back. $nvo priced as a bargain, I had to grab some today. Don’t need to bet on buyouts, there are some strong pharma/biotechs that have been cut 30% in a month or two

User Image the_big_gains Posted - 12 hours ago

$VKTX nice short term convergence creating a symmetric triangle. Looking for a big breakout upward out of this triangle.

User Image BlondeAmbition Posted - 12 hours ago

$VKTX Adding

User Image Hotresearchsgoldenage Posted - 12 hours ago

$VKTX if we get a buyout over the weekend? I’ll take it ! This stock just rides the waves like a surfer who smoked pot ! No matter the news ? No cares given ! lol

User Image jenbunn Posted - 12 hours ago

@cubie @EBE_Day @indievestments @simon58 @judgeyoung2 @Ollip @ribbey @TraderRapp @tonyctl @lukenight the day will come I believe…. $vktx… I will be checking that chain in about an ohour… these f’ers get in last minute, if and when they want

User Image cubie Posted - 12 hours ago

@indievestments @simon58 @judgeyoung2 @jenbunn @EBE_Day @Ollip @ribbey @TraderRapp @tonyctl @lukenight cubie learned $vktx options decay faster than others!

Analyst Ratings
Oppenheimer Outperform Sep 25, 24
Morgan Stanley Overweight Sep 12, 24
JP Morgan Overweight Sep 11, 24
Raymond James Strong Buy Jul 25, 24
HC Wainwright & Co. Buy Jul 25, 24
Morgan Stanley Overweight Jun 27, 24
HC Wainwright & Co. Buy Jun 24, 24
Truist Securities Buy Jun 17, 24
Raymond James Strong Buy Jun 4, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Lian Brian President & CEO President & CEO Jan 31 Sell 24.7 85,000 2,099,500 2,264,882 01/31/24
Lian Brian President & CEO President & CEO Jan 31 Option 1.23 85,000 104,550 2,349,882 01/31/24
Lian Brian President & CEO President & CEO Jan 30 Sell 23.95 35,000 838,250 2,264,882 01/30/24
Lian Brian President & CEO President & CEO Jan 30 Option 1.23 35,000 43,050 2,299,882 01/30/24
Rouan Sarah Kathryn Director Director Jan 19 Sell 23.05 30,000 691,500 01/19/24
Rouan Sarah Kathryn Director Director Jan 19 Option 8.32 30,000 249,600 30,000 01/19/24
ZANTE GREG Chief Financial Offi.. Chief Financial Officer Jan 03 Sell 17.9 15,000 268,500 180,730 01/04/24
Rowland Charles A Jr Director Director May 16 Option 1.08 40,000 43,200 70,000 05/18/23
Rowland Charles A Jr Director Director May 16 Sell 25 40,000 1,000,000 30,000 05/18/23
MACARTNEY LAWSON Director Director May 16 Sell 24 16,000 384,000 47,965 05/18/23
MACARTNEY LAWSON Director Director May 16 Option 1.19 16,000 19,040 63,965 05/18/23
Lian Brian President & CEO President & CEO May 01 Sell 22.45 45,000 1,010,250 2,197,963 05/01/23
MACARTNEY LAWSON Director Director Apr 24 Sell 22 16,000 352,000 47,965 04/24/23
MACARTNEY LAWSON Director Director Apr 24 Option 3.33 16,000 53,280 63,965 04/24/23
Lian Brian President & CEO President & CEO Apr 19 Sell 21.45 35,000 750,750 2,242,963 04/21/23
MACARTNEY LAWSON Director Director Apr 17 Sell 20 20,786 415,720 47,965 04/18/23
MACARTNEY LAWSON Director Director Apr 17 Option 8 20,786 166,288 68,751 04/18/23
Lian Brian President & CEO President & CEO Apr 17 Sell 20.45 155,000 3,169,750 2,277,963 04/18/23
Lian Brian President & CEO President & CEO Apr 17 Option 2.15 125,000 268,750 2,432,963 04/18/23
Mancini Marianna Chief Operating Offi.. Chief Operating Officer Apr 17 Sell 20 12,500 250,000 287,763 04/18/23
Mancini Marianna Chief Operating Offi.. Chief Operating Officer Apr 17 Option 13.07 12,500 163,375 300,263 04/18/23
ZANTE GREG Chief Financial Offi.. Chief Financial Officer Apr 17 Sell 20 7,500 150,000 149,279 04/18/23
ZANTE GREG Chief Financial Offi.. Chief Financial Officer Apr 17 Option 13.07 7,500 98,025 156,779 04/18/23
Lian Brian President & CEO President & CEO Apr 13 Sell 18.45 79,336 1,463,749 2,307,963 04/13/23
Lian Brian President & CEO President & CEO Apr 13 Option 1.88 54,336 102,152 2,387,299 04/13/23
ZANTE GREG Chief Financial Offi.. Chief Financial Officer Apr 11 Sell 18 97,839 1,761,102 149,279 04/13/23
ZANTE GREG Chief Financial Offi.. Chief Financial Officer Apr 11 Option 6.12 97,839 598,775 190,823 04/13/23
Lian Brian President & CEO President & CEO Mar 30 Sell 17.43 243,352 4,241,625 2,232,963 04/03/23
Lian Brian President & CEO President & CEO Mar 30 Option 6.74 203,352 1,370,592 2,322,933 04/03/23
ZANTE GREG Chief Financial Offi.. Chief Financial Officer Mar 30 Sell 17.5 161,940 2,833,950 147,778 04/03/23
ZANTE GREG Chief Financial Offi.. Chief Financial Officer Mar 30 Option 6.55 124,661 816,530 178,689 04/03/23
Mancini Marianna Chief Operating Offi.. Chief Operating Officer Mar 30 Option 9.92 72,200 716,224 261,895 04/03/23
Mancini Marianna Chief Operating Offi.. Chief Operating Officer Mar 28 Sell 15.5 237,805 3,685,978 261,895 03/30/23
Mancini Marianna Chief Operating Offi.. Chief Operating Officer Mar 28 Option 2.98 182,427 543,632 303,137 03/30/23